Literature DB >> 21108326

Laboratory tests for antithrombin deficiency.

Bernard Khor1, Elizabeth M Van Cott.   

Abstract

Hereditary antithrombin deficiency is a hypercoagulable state associated with an increased risk for venous thrombosis. The recommended initial test for antithrombin is an activity (functional) assay. The advantages and disadvantages of the various testing options are presented. The causes of acquired antithrombin deficiency are much more common than hereditary deficiency. Therefore, this article describes the appropriate steps to take when antithrombin activity is low, in order to confirm or exclude a hereditary deficiency. The causes of falsely normal results are also described, including direct thrombin inhibitors. Am. J. Hematol. 85:947-950, 2010.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21108326     DOI: 10.1002/ajh.21893

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Quite a backup: pericardial varices in a patient with hereditary antithrombin deficiency.

Authors:  Jason N Salamon; Santhosh Mannem; Mark Guelfguat
Journal:  Quant Imaging Med Surg       Date:  2013-06

2.  Multiple Retinal Vein Occlusions Associated with Anti-thrombin III Deficiency.

Authors:  Ramin Nourinia; Talie Montahaei; Bahareh Behdad; Ali Aghajani
Journal:  J Ophthalmic Vis Res       Date:  2015 Oct-Dec

3.  Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever.

Authors:  Zulal Ozkurt; Kemalettin Ozden; Ilhami Kiki; Mustafa Usanmaz
Journal:  Eurasian J Med       Date:  2011-08

Review 4.  Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.

Authors:  Khue Vu Nguyen
Journal:  AIMS Neurosci       Date:  2022-04-21

5.  Defining the boundaries of normal thrombin generation: investigations into hemostasis.

Authors:  Christopher M Danforth; Thomas Orfeo; Stephen J Everse; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

Review 6.  Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.

Authors:  Megan O Nakashima; Heesun J Rogers
Journal:  Blood Res       Date:  2014-06-25

7.  Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature.

Authors:  Mohammad Refaei; Lydia Xing; Wendy Lim; Mark Crowther; Kochawan Boonyawat
Journal:  Case Rep Hematol       Date:  2017-01-10

8.  A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.

Authors:  Jingjing Su; Liang Shu; Zhou Zhang; Lei Cai; Xin Zhang; Yu Zhai; Jianren Liu
Journal:  Oncotarget       Date:  2016-11-22

9.  Emergency cardiac surgery and heparin resistance in a patient with essential thrombocythemia.

Authors:  Mika Nakanishi; Eri Oota; Takehiro Soeda; Kaoru Masumo; Yukihiko Tomita; Takeshi Kato; Toshihiro Imanishi
Journal:  JA Clin Rep       Date:  2016-11-09

10.  Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.

Authors:  Jiong-Wei Wang; Ya-Nan Zhang; Siu Kwan Sze; Sander M van de Weg; Flora Vernooij; Arjan H Schoneveld; Sock-Hwee Tan; Henri H Versteeg; Leo Timmers; Carolyn S P Lam; Dominique P V de Kleijn
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.